Relmada Therapeutics Inc

RLMD

Add to Watchlist

4.765USD

-0.035-0.72%

Market hours （ET）Quotes delayed by 15 min

508.32MMarket Cap

LossP/E TTM

Relmada Therapeutics Inc

4.765

-0.035-0.72%

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Follow the latest Relmada Therapeutics Inc stock news, earnings, analyst ratings and key developments.

Recent

Relmada Q2 2026 earnings: R&D spending rises ahead of planned IND filings

TradingKey Fri, Aug 7